The pharmaceutical industry relies on a vast array of specialized chemical compounds to develop and manufacture life-saving medicines. Among these, chemical intermediates play a foundational role, acting as crucial building blocks in complex synthetic pathways. This guide provides an in-depth look at N-(2,6-Dimethylphenyl)-1-piperazineacetamide, exploring its key characteristics, its primary application, and essential considerations for sourcing this vital compound.

Understanding the Chemical Profile: N-(2,6-Dimethylphenyl)-1-piperazineacetamide

N-(2,6-Dimethylphenyl)-1-piperazineacetamide, identified by its CAS number 5294-61-1, is a white to off-white crystalline powder. Its molecular formula is C14H21N3O, and its molecular weight is approximately 247.34 g/mol. The compound's physical form and chemical stability are important for its handling and use in synthesis. Key properties often highlighted include its typical assay of ≥98.0%, indicating a high degree of purity essential for pharmaceutical applications. Storage recommendations usually advise keeping it in a cool, well-ventilated place to maintain its integrity.

Primary Application: A Cornerstone in Ranolazine Synthesis

The most well-documented and critical application of N-(2,6-Dimethylphenyl)-1-piperazineacetamide is its use as an intermediate in the synthesis of Ranolazine. Ranolazine is a medication prescribed for the long-term treatment of chronic stable angina pectoris, a condition causing chest pain due to insufficient blood flow to the heart. The synthesis of Ranolazine involves multiple steps, and N-(2,6-Dimethylphenyl)-1-piperazineacetamide provides a key structural component that is carried through to the final API. Therefore, for companies involved in the production of Ranolazine, understanding how to buy N-(2,6-dimethylphenyl)-1-piperazineacetamide efficiently and reliably is paramount.

Why Source High-Purity Intermediates?

The decision to purchase N-(2,6-dimethylphenyl)-1-piperazineacetamide with a high assay specification (≥98.0%) is driven by several critical factors in pharmaceutical manufacturing:

• Process Efficiency: Higher purity intermediates lead to more predictable reactions, fewer side products, and often higher yields of the desired API.
• Reduced Purification Burden: Minimizing impurities in the starting materials simplifies downstream purification processes, saving time and resources.
• Regulatory Compliance: Pharmaceutical regulatory bodies have strict guidelines regarding impurity profiles in APIs. Using pure intermediates helps meet these requirements.
• Cost-Effectiveness: While higher purity might seem more expensive initially, the reduction in processing steps, waste, and potential batch failures often makes it more cost-effective overall.

A reliable N-(2,6-dimethylphenyl)-1-piperazineacetamide supplier will provide detailed documentation, including Certificates of Analysis, to verify the purity and quality of their product.

Sourcing Strategies for Pharmaceutical Buyers

When seeking to source N-(2,6-Dimethylphenyl)-1-piperazineacetamide, pharmaceutical buyers should consider the following:

• Supplier Reputation: Look for established manufacturers with a proven track record in producing pharmaceutical intermediates.
• Quality Management Systems: Verify that the supplier operates under robust quality management systems, such as ISO certifications.
• Technical Data: Ensure comprehensive technical data, including detailed specifications and safety information, is readily available.
• Packaging and Storage: Confirm that the packaging is suitable for maintaining product integrity during transport and storage, and that recommended storage conditions are clear.

NINGBO INNO PHARMCHEM CO.,LTD. positions itself as a dependable source for such critical pharmaceutical intermediates, supporting the needs of drug manufacturers worldwide.

In conclusion, N-(2,6-Dimethylphenyl)-1-piperazineacetamide is an indispensable compound in the pharmaceutical industry, particularly for the synthesis of Ranolazine. Prioritizing high purity and selecting a trustworthy supplier are key steps towards ensuring efficient, compliant, and high-quality pharmaceutical manufacturing. By focusing on these aspects, companies can better navigate the complexities of API production and contribute to the availability of essential medicines.